Risk assessment in haematopoietic stem cell transplantation: Minor histocompatibility antigens

Best Practice and Research in Clinical Haematology

Volumn 20, Issue 2, 2007, Pages 171-187

  Hambach, Lothar ^a   Spierings, Eric ^a   Goulmy, Els ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

allogeneic stem cell transplantation; graft versus host disease; graft versus tumour effect; immunotherapy; minor histocompatibility antigens

Indexed keywords

MINOR HISTOCOMPATIBILITY ANTIGEN; MINOR HISTOCOMPATIBILITY ANTIGEN PEPTIDE VACCINE; UNCLASSIFIED DRUG; VACCINE;

ALLOGENEIC STEM CELL TRANSPLANTATION; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; CANCER CELL; CANCER IMMUNOTHERAPY; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL TRIAL; DONOR; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNIZATION; LYMPHOCYTE TRANSFUSION; MOLECULAR TYPING; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; TISSUE DISTRIBUTION; TREATMENT OUTCOME;

CANCER VACCINES; FEMALE; GRAFT VS HOST DISEASE; GRAFT VS TUMOR EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MINOR HISTOCOMPATIBILITY ANTIGENS; NEOPLASMS; PREGNANCY; RISK ASSESSMENT; TRANSPLANTATION, HOMOLOGOUS;

EID: 34247171693     PISSN: 15216926     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beha.2006.09.002     Document Type: Review

References (71)

1. Goulmy E. Human minor histocompatibility antigens. Current Opinion in Immunology 8 75 (1996) 81
2. Goulmy E., Termijtelen A., Bradley B., et al. Y-antigen killing by T cells of women is restricted by HLA. Nature 266 (1977) 544-545
3. Goulmy E., Termijtelen A., Bradley B., et al. Alloimmunity to human H-Y. Lancet 308 7996 (1976) 1206
4. Voogt P., Fibbe W., Marijt W.A., et al. Rejection of bone marrow graft by recipient-derived cytotoxic T lymphocytes against minor histocompatibility antigens. Lancet 335 (1990) 131-134
5. Horowitz M., Gale R., Sondel P., et al. Graft-verus-leukemia reactions after bone-marrow transplantation. Blood 75 (1990) 555-562
6. Kolb H., Mittermuller J., Clemm C., et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 76 12 (1990) 2462-2465
7. Atkinson K., Farrell C., Chapman G., et al. Female marrow donors increase the risk of acute graft-versus-host disease: effect of donor age and parity and analysis of cell subpopulations in the donor marrow inoculum. British Journal of Haematology 63 2 (1986) 231-239
8. Gratwohl A., Hermans J., Niederwieser D., et al. Female donors influence transplant-related mortality and relapse incidence in male recipients of sibling blood and marrow transplants. The Hematology Journal 2 6 (2001) 363-370
9. Randolph S.S., Gooley T.A., Warren E.H., et al. Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants. Blood 103 1 (2004) 347-352
10. Takami A., Sugimori C., Feng X., et al. Expansion and activation of minor histocompatibility antigen HY-specific T cells associated with graft-versus-leukemia response. Bone Marrow Transplantation 34 8 (2004) 703-709
11. Gahrton G., Iacobelli S., Apperley J., et al. The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplants. Bone Marrow Transplantation 35 6 (2005) 609-617
12. de Bueger M., Bakker A., van Rood J., et al. Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicated heterogenity among human cytotoxic T lymphocyte-defined non-MHC antigens. Journal of Immunology 149 5 (1992) 1788-1794
13. Dickinson A., Wang X., Sviland L., et al. In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens. Nature Medicine 8 4 (2002) 410-414
14. van Lochem E., van der Keur M., Mommaas A.M., et al. Functional expression of minor histocompatibility antigens on human peripheral blood dendritic cells and epidermal Langerhans cells. Transplant Immunology 4 2 (1996) 151-157
15. van der Harst D., Goulmy E., Falkenburg J., et al. Recognition of minor histocompatibility antigens on lymphocytic and myeloid leukemic cells by cytotoxic T-cell clones. Blood 83 (1994) 1060-1066
16. Marijt W., Heemskerk M., Kloosterboer F., et al. Hematopoiesis-restricted minor histocompatibilty antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia. Proceedings of the National Academy of Sciences of the United States of America 100 5 (2003) 2742-2747
17. Klein C., Wilke M., Pool J., et al. The hematopoietic system-specific minor histocompatibility antigen HA-1 shows aberrant expression in epithelial cancer cells. The Journal of Experimental Medicine 196 3 (2002) 359-368
18. Tykodi S., Warren E., Thompson J., et al. Allogeneic hematopoietic cell transplantation for metastatic renal cell carcinoma after nonmyeloablative conditioning: toxicity, clinical response, and immunological response to minor histocompatibility antigens. Clinical Cancer Research 10 23 (2004) 7799-7811
19. Spierings E., Wieles B., and Goulmy E. Minor histocompatibility antigens - big in tumour therapy. Trends in Immunology 25 2 (2004) 56-60
20. Akatsuka Y., Nishida T., Kondo E., et al. Identification of a polymorphic gene, BCL2A1, encoding two novel hematopoietic linegae-specific minor histocompatibility antigens. The Journal of Experimental Medicine 197 11 (2003) 1489-1500
21. Shlomchik W., Couzens M., Tang C., et al. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 285 5426 (1999) 412-419
22. Mapara M., Kim Y., Wang S., et al. Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen-presenting cells. Blood 100 (2002) 1903-1909
23. Matte C., Liu J., Cormier J., et al. Donor APCs are required for maximal GvHD but not for GvL. Nature Medicine 10 9 (2004) 987-992
24. Collin M.P., Hart D.N., Jackson G.H., et al. The fate of human Langerhans cells in hematopoietic stem cell transplantation. The Journal of Experimental Medicine 203 1 (2006) 27-33
25. Goulmy E., Schnipper R., Pool J., et al. Mismatches of minor histocompatibility antigens between HLA-identical donors and recepients and the development of graft-versus-host disease after bone marrow transplantation. The New England Journal of Medicine 334 (1996) 281-285
26. Tait B., Maddison R., McCluskey J., et al. Clinical relevance of the minor histocompatibility antigen HA-1 in allogeneic bone marrow transplantation between HLA identical siblings. Transplantation Proceedings 33 (2001) 1760-1761
27. Socié G., Loiseau P., Tamouza R., et al. Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Transplantation 72 4 (2001) 699-706
28. Gallardo D., Arostegui J., Balas A., et al. Disparity for the minor histocompatibility antigen HA-1 is associated with an increased risk of acute graft-versus-host disease (GvHD) but it does not affect chronic GvHD incidence, disease-free survival or overall survival after allogeneic human leucocyte antigen-identical sibbling donor transplantation. British Journal of Haematology 114 (2001) 931-936
29. Kolb H.J., Rank A., Chen X., et al. In-vivo generation of leukaemia-derived dendritic cells. Best Practice & Research. Clinical Haematology 17 3 (2004) 439-451
30. Hambach L., and Goulmy E. Immunotherapy of cancer through targeting of minor histocompatibility antigens. Current Opinion in Immunology 17 (2005) 202-210
31. Kollman C., Howe C., Anasetti C., et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood 98 7 (2001) 2043-2051
32. Verdijk R., Pool J., van der Keur M., et al. Pregnancy induces minor histocompatibility antigen-specific cytotoxic T cells: implications for stem cell transplantation and immunotherapy. Blood 103 5 (2004) 1961-1963
33. James E., Chai J., Dewchand H., et al. Multiparity induces priming to male-specific minor histocompatibility antigen, HY, in mice and humans. Blood 102 1 (2003) 388-393
34. Mommaas B., Stegehuis-Kamp J., van Halteren A., et al. Cord blood comprises antigen-experienced T cells specific for maternal minor histocompatibility antigen HA-1. Blood 105 4 (2004) 1823-1827
35. Goulmy E., Hamilton J., Bradley B., et al. HLA restricted killing of male targerts by multi-transfused females in the cell mediated lympholysis test. Cell Biology and Immunology of Leucocyte Function (1979) 589-594
36. den Haan J., Meadows L., Wang W., et al. The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism. Science 279 (1998) 1054-1057
37. Mommaas B., Kamp J., Drijfhout J., et al. Identification of a novel HLA-B60-restricted T cell epitope of the minor histocompatibility antigen HA-1 locus. Journal of Immunology 169 6 (2003) 3131-3136
38. Slager E.H., Honders M.W., van der Meijden E.D., et al. Identification of the angiogenic endothelial-cell growth factor-1/thymidine phosphorylase as a potential target for immunotherapy of cancer. Blood 107 12 (2006) 4954-4960
39. den Haan J., Sherman N., Blokland E., et al. Identification of a graft versus host disease-associated human mior histocompatibility antigen. Science 268 (1995) 1476-1480
40. Dolstra H., Fredrix H., Maas F., et al. A human minor histocompatibility antigen specific for B cell acute lymphoblastic leukemia. The Journal of Experimental Medicine 189 2 (1999) 301-308
41. Brickner A.G., Evans A.M., Mito J.K., et al. The PANE1 gene encodes a novel human minor histocompatibility antigen that is selectively expressed in B-lymphoid cells and B-CLL. Blood 107 9 (2006) 3779-3786
42. de Rijke B., Horssen-Zoetbrood A., Beekman J.M., et al. A frameshift polymorphism in P2X5 elicits an allogeneic cytotoxic T lymphocyte response associated with remission of chronic myeloid leukemia. The Journal of Clinical Investigation 115 12 (2005) 3506-3516
43. Mutis T., Verdijk R., Schrama E., et al. Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens. Blood 93 (1999) 2336-2341
44. Hambach L., Nijmeijer B., Aghai Z., et al. Human cytotoxic T lymphocytes specific for a single minor histocompatibility antigen HA-1 are effective against human lymphoblastic leukaemia in NOD/scid mice. Leukemia 20 (2006) 371-374
45. Heemskerk M., Hoogeboom M., de Paus R., et al. Redirection of antileukemic reactivity of peripheral T lymphocytes using gene transfer of minor histocompatibility antigen HA-2-specific T-cell receptor complexes expressing a conserved alpha joining region. Blood 102 10 (2003) 3530-3540
46. Mommaas B., van Halteren A.G., Pool J., et al. Adult and cord blood T cells can acquire HA-1 specificity through HA-1 T-cell receptor gene transfer. Haematologica 90 10 (2005) 1415-1421
47. Minor H antigen database. http://www.lumc.nl/dbminor.
48. Vogt M., van den Muijsenberg J., Goulmy E., et al. The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease. Blood 99 8 (2002) 3027-3032
49. Spierings E., Vermeulen C., Vogt M., et al. Identification of HLA class II-restricted H-Y specific T helper epitope evoking CD4+ T-helper cells in H-Y-mismatched transplantation. Lancet 362 9384 (2003) 590-591
50. Zorn E., Miklos D.B., Floyd B.H., et al. Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation. The Journal of Experimental Medicine 199 8 (2004) 1133-1142
51. Spierings E., Brickner A., Caldwell J., et al. The minor Histocompatibility antigen HA-3 arises from differential proteasome-mediated cleavage of the lymphoid blast crisis (Lbc) oncoprotein. Blood 102 2 (2003) 621-629
52. de Bueger M., Bakker A., and Goulmy E. Acquired tolerance for minor Histocompatibility antigens after HLA identical bone marrow transplantation. International Immunology 4 (1992) 53-57
53. Boeck S., Hamann M., Pihusch V., et al. Kinetics of dendritic cell chimerism and T cell chimerism in allogeneic hematopoietic stem cell recipients. Bone Marrow Transplantation 37 1 (2006) 57-64
54. van Els C., D'Amaro J., Pool J., et al. Immunogenetics of human minor histocompatibility antigens: their polymorphism and immunodominance. Immunogenetics 35 (1992) 161-165
55. Kloosterboer F.M., Luxemburg-Heijs S.A., van Soest R.A., et al. Direct cloning of leukemia-reactive T cells from patients treated with donor lymphocyte infusion shows a relative dominance of hematopoiesis-restricted minor histocompatibility antigen HA-1 and HA-2 specific T cells. Leukemia 18 4 (2004) 798-808
56. Rufer N., Wolpert E., Helg C., et al. HA-1 and the SMCY-derived peptide fidsyicqv (H-Y) are immunodominant minor Histocompatibility antigens after bone marrow transplantation. Transplantation 66 (1998) 910-967
57. Goulmy E., Blokland E., Fassbinder W., et al. Occurrence of posttransplant donor-specific cell-mediated lympholysis nonreactivity in renal allograft recipients with perioperative transfusions only. Transplantation 39 1 (1985) 105-107
58. Cai J., Lee J., Jankowska-Gan E., et al. Minor H antigen HA-1-specific regulator and effector CD8+ T cells, and HA-1 microchimerism, in allograft tolerance. The Journal of Experimental Medicine 199 7 (2004) 1017-1023
59. Hambach L., Nijmeijer B.A., Drabbels J.J., et al. Chromosomal aberrations in leukaemia cells may delete tumour target antigens of stem cell-based immunotherapy. Leukemia 20 7 (2006) 1298-1300
60. Miyazaki M., Akatsuka Y., Nishida T., et al. Potential limitations in using minor histocompatibility antigen-specific cytotoxic T cells for targeting solid tumor cells. Clinical Immunology 107 3 (2003) 198-201
61. Murata M., Warren E., and Riddell S. A human minor histocompatibility antigen resutling from differential expression due to a gene deletion. The Journal of Experimental Medicine 197 10 (2003) 1279-1289
62. Warren E., Gavin M., Simpson E., et al. The human UTY gene encodes a novel HLA-B8-restricted H-Y antigen. Journal of Immunology 164 5 (2000) 2807-2814
63. Ivanov R., Aarts T., Hol S., et al. Identification of a 40S ribosomal protein S4-derived H-Y epitope able to elicit a lymphoblast-specific cytotoxic T lymphocyte response. Clinical Cancer Research 11 5 (2005) 1694-1703
64. Pierce R., Field E., den Haan J., et al. Cutting edge: the HLA-A*0101-restricted HY minor histocompatibility antigen originates from DFFRY and contains a cysteinylated cyteine residue as identified by a novel mass spectrometric technique. Journal of Immunology 163 12 (1999) 6360-6364
65. Vogt M., de Paus R., Voogt P., et al. DFFRY codes for a new human male-specific minor transplantation antigen involved in bone marrow graft rejection. Blood 95 3 (2000) 1100-1105
66. Meadows L., Wang W., den Haan J., et al. The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition. Immunity 6 3 (1997) 273-281
67. Brickner A., Warren E., Caldwell J., et al. The Immunogenicity of a new human minor histocompatibility antigen results from differential antigen processing. The Journal of Experimental Medicine 193 2 (2001) 15-205
68. Torikai H., Akatsuka Y., Miyazaki M., et al. A novel HLA-A*3303-restricted minor histocompatibility antigen encoded by an unconventional open reading frame of human TMSB4Y gene. Journal of Immunology 173 11 (2004) 7046-7054
69. Wang W., Meadows L., den Haan J., et al. Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein. Science 269 5230 (1995) 1588-1590
70. Vogt M., Goulmy E., Kloosterboer F., et al. UTY gene codes for an HLA-B60-restricted human male-specific minor histocompatibility antigen involved in stem cell graft rejection: characterization of the critical polymorphic amino acid residues for T-cell recognition. Blood 96 (2000) 3126-3132
71. Spierings E, Drabbels J, Hendriks M et al. Uniform genomic minor histocompatibility antigen typing methodology and database designed to facilitate clinical applications. PLoS One 2006, in press.